GtoPdb Ligand ID: 9295

Synonyms: emapalumab-lzsg | Gamifant® | NI-0501 | NI0501
emapalumab is an approved drug (FDA (2018))
Compound class: Antibody
Comment: Emapalumab (NI-0501) is a fully human monoclonal antibody that targets interferon gamma (IFNγ).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2006109191, and in which NI-0501 is confirmed as an exemplary antibody [2].
Compound class Antibody
Approved drug? Yes (FDA (2018))
International Nonproprietary Names
INN number INN
10319 emapalumab
emapalumab-lzsg | Gamifant® | NI-0501 | NI0501
Database Links
Specialist databases
IMGT/mAb-DB 666
Other databases
GtoPdb PubChem SID 318164814
Search PubMed clinical trials emapalumab
Search PubMed titles emapalumab
Search PubMed titles/abstracts emapalumab